Tuberculosis in patients with human immunodeficiency virus infection

Seminars in Respiratory Infections

Volumn 14, Issue 4, 1999, Pages 344-352

  Perlman, David C ^a,b   El Helou, Philippe ^a   Salomon, Nadim ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN;

DIAGNOSTIC TEST; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TUBERCULIN TEST;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; HUMANS; PREVALENCE; TUBERCULOSIS, PULMONARY;

EID: 0033428018     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)